{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:20:36Z","timestamp":1765538436605,"version":"3.48.0"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_JBCPP-2021-0345_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The study underwent to evaluate the adverse events, the incidence of COVID-19 and the participant\u2019s attitude and perception towards the vaccine following Sputnik V administration through an active surveillance program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_JBCPP-2021-0345_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The prospective observational study was conducted four months in the Sputnik V vaccination center that enrolled 700 participants. Sociodemographic details, medical histories, COVID-19 incidences and adverse events following immunization (AEFI) of each sample were collected through face-to-face interviews and a telephonic feedback system. A self-prepared and validated questionnaire addressed their acceptances and perceptions towards the vaccination drive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_JBCPP-2021-0345_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study reported 42.1% of AEFIs after the first dose and 9.1% after the second. Fever, pain at the injection site, body pain, headache and fatigue were predominant, while dizziness and diarrhoea were rare. However, AEFIs were not influenced by the presence of comorbidities (p\u00a0&gt;\u00a00.05). On the other hand, there were limited post immunization (1.8%) COVID-19 patients and that too with minor severity (p\u00a0&lt;\u00a00.01). Our participants were overall satisfied with the Sputnik V immunization. However, those presented with AEFIs on the consecutive three days depicted slightly declined gratification (p\u00a0&lt;\u00a00.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_JBCPP-2021-0345_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our pharmacist-directed surveillance program on Sputnik V showed fewer events of AEFIs and negligible occurrence of COVID19 following immunization. Moreover, the population had appreciable attitude and positive perceptions towards Sputnik V vaccination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jbcpp-2021-0345","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T17:46:26Z","timestamp":1645033586000},"page":"509-517","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India"],"prefix":"10.1515","volume":"34","author":[{"given":"Mohammed Salim","family":"Karattuthodi","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Chandrasekher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linu Mohan","family":"Panakkal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinu","family":"C","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Salman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Megha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Swabeeh","family":"E","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Fasil","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"A M","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Reji","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice , Al Shifa College of Pharmacy, Kerala University of Health Sciences , Kizhattoor , Kerala , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_001","doi-asserted-by":"crossref","unstructured":"Department of Pharmacology, Government Medical College, Gondia, Maharashtra, India, Jaiswal KM, Dudhgaonkar S, Department of Pharmacology, Government Medical College, Gondia, Maharashtra, India, Raghute L, Department of Pharmacology, Government Medical College, Gondia, Maharashtra, India, et al.. An assessment of AEFI COVID-19 vaccination in health care workers at a tertiary health care centre in central India. Microbiol Res Int. 2021;9:46\u201350.","DOI":"10.30918\/MRI.92.21.017"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_002","doi-asserted-by":"crossref","unstructured":"Kunal, S, Sakthivel, P, Gupta, N, Ish, P. Mix and match COVID-19 vaccines: potential benefit and perspective from India. Postgrad Med 2021. https:\/\/doi.org\/10.1136\/postgradmedj-2021-140648.","DOI":"10.1136\/postgradmedj-2021-140648"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_003","doi-asserted-by":"crossref","unstructured":"Kim, M-A, Lee, YW, Kim, SR, Kim, J-H, Min, T k, Park, H-S, et al.. COVID-19 vaccine-associated anaphylaxis and allergic reactions: consensus statements of the KAAACI urticaria\/angioedema\/anaphylaxis working group. Allergy Asthma Immunol Res. 2021;13:526\u201344, https:\/\/doi.org\/10.4168\/aair.2021.13.4.526.","DOI":"10.4168\/aair.2021.13.4.526"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_004","doi-asserted-by":"crossref","unstructured":"Siddique, S, Ahmed, S. COVID-19 vaccines in Pakistan: efficacy, adverse effects and availability. J Islamabad Med Dent College. 2021;10:125\u201330, https:\/\/doi.org\/10.35787\/jimdc.v10i2.723.","DOI":"10.35787\/jimdc.v10i2.723"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_005","doi-asserted-by":"crossref","unstructured":"Ahmad, S, Singh, S, Wasim, S, Rai, S. Adverse event following immunization (AEFI) and COVID-19 vaccination: a review. Int J Curr Microbiol Appl Sci. 2021;10:555\u201365.","DOI":"10.20546\/ijcmas.2021.1006.061"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_006","doi-asserted-by":"crossref","unstructured":"Hasan, T, Beardsley, J, Marais, BJ, Nguyen, TA, Fox, GJ. The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines. 2021;9:326, https:\/\/doi.org\/10.3390\/vaccines9040326.","DOI":"10.3390\/vaccines9040326"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_007","doi-asserted-by":"crossref","unstructured":"Leghari, Q, Chand, SK, Bushra, R, Rizvi, M, Khan, M, Shahnaz, S, et al.. Exploration of perception, need and barriers against pharmacovigilance and adverse drug reactions reporting: healthcare professionals\u2019 insight. J Pharm Res Int 2021;33:78\u201386. https:\/\/doi.org\/10.9734\/jpri\/2021\/v33i731204.","DOI":"10.9734\/jpri\/2021\/v33i731204"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_008","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134, https:\/\/doi.org\/10.1001\/jama.2013.281053.","DOI":"10.1001\/jama.2013.281053"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_009","unstructured":"National Health Authority. CoWIN [Online]. Available from: https:\/\/www.cowin.gov.in\/ [cited 2021 Nov 9]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_010","unstructured":"National Health Authority. Aarogya Setu [Online]. Available from: https:\/\/aarogyasetu.gov.in\/ [cited 2021 Nov 9]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_011","doi-asserted-by":"crossref","unstructured":"Chauhan, S Pharmacovigilance-A drug safety monitoring tool. J\u00a0Pharmacovigil Drug Res. 2021;2:15\u201320, https:\/\/doi.org\/10.53411\/jpadr.2021.2.3.4.","DOI":"10.53411\/jpadr.2021.2.3.4"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_012","unstructured":"World Health Organisation. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification, 2nd ed., Geneva: World Health Organisation; 2019 [Online]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/causality-assessment-aefi-user-manual-2019 [cited 2021 Nov 9]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_013","doi-asserted-by":"crossref","unstructured":"Montalti, M, Sold\u00e0, G, Di Valerio, Z, Salussolia, A, Lenzi, J, Forcellini, M, et al.. ROCCA observational study: early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance. EClinicalMedicine. 2021;38:101027, https:\/\/doi.org\/10.1016\/j.eclinm.2021.101027.","DOI":"10.1016\/j.eclinm.2021.101027"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_014","doi-asserted-by":"crossref","unstructured":"Novelli, G, Colona, VL, Pandolfi, PP. A focus on the spread of the delta variant of SARS-CoV-2 in India. Indian J Med Res. 2021;153:537\u201341, https:\/\/doi.org\/10.4103\/ijmr.ijmr_1353_21.","DOI":"10.4103\/ijmr.ijmr_1353_21"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_015","doi-asserted-by":"crossref","unstructured":"Lustig, Y, Zuckerman, N, Nemet, I, Atari, N, Kliker, L, Regev-Yochay, G, et al.. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech\/Pfizer) vaccination in health care workers, Israel. Eurosurveillance. 2021;26:2100557, https:\/\/doi.org\/10.2807\/1560-7917.es.2021.26.26.2100557.","DOI":"10.2807\/1560-7917.ES.2021.26.26.2100557"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_016","doi-asserted-by":"crossref","unstructured":"Parums, DV. Editorial: revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2. Med Sci Monit. 2021;27:e933622-1\u2013e933622-2, https:\/\/doi.org\/10.12659\/MSM.933622.","DOI":"10.12659\/MSM.933622"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_017","doi-asserted-by":"crossref","unstructured":"Singh, UB, Rophina, M, Chaudhry, R, Senthivel, V, Bala, K, Bhoyar, RC, et al.. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India. J Med Virol [Online]; 1-5. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jmv.27461 [cited 2022 Jan 12].","DOI":"10.31219\/osf.io\/fgd4x"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_018","doi-asserted-by":"crossref","unstructured":"Logunov, DY, Dolzhikova, IV, Shcheblyakov, DV, Tukhvatulin, AI, Zubkova, OV, Dzharullaeva, AS, et al.. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397:671\u201381, https:\/\/doi.org\/10.1016\/s0140-6736(21)00234-8.","DOI":"10.1016\/S0140-6736(21)00234-8"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_019","doi-asserted-by":"crossref","unstructured":"Cazzola, M, Rogliani, P, Mazzeo, F, Matera, MG. Controversy surrounding the Sputnik V vaccine. Respir Med. 2021;187:106569, https:\/\/doi.org\/10.1016\/j.rmed.2021.106569.","DOI":"10.1016\/j.rmed.2021.106569"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_020","doi-asserted-by":"crossref","unstructured":"Deming, ME, Lyke, KE. A \u2018mix and match\u2019 approach to SARS-CoV-2 vaccination. Nat Med. 2021;27:1510\u20131, https:\/\/doi.org\/10.1038\/s41591-021-01463-x.","DOI":"10.1038\/s41591-021-01463-x"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_021","doi-asserted-by":"crossref","unstructured":"Jaiswal, KM, Dudhgaonkar, S, Raghute, L, Uike, P, Kohli, S, Anand, I. An assessment of AEFI COVID-19 vaccination in health care workers at a tertiary health care centre in central India.Microbio. Res Int 2021;9:46\u201350.","DOI":"10.30918\/MRI.92.21.017"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_022","doi-asserted-by":"crossref","unstructured":"Zimmermann, P, Curtis, N. Factors that influence the immune response to vaccination. Clin Microbiol Rev 2019;32. https:\/\/doi.org\/10.1128\/cmr.00084-18.","DOI":"10.1128\/CMR.00084-18"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_023","unstructured":"Kuntal, B, Lakshmi, GN, Deepshikha, M, Shashivadhanan, S. Patterns of antibody response, adverse effects, and knowledge regarding COVID-19 vaccine: findings of a serosurvey among vaccinated individuals in north-western India. 2001 [Online]. Available from: https:\/\/www.marinemedicalsociety.in\/preprintarticle.asp?id=326739 [cited 2021 Oct 25]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_024","doi-asserted-by":"crossref","unstructured":"Johansson, MA, Quandelacy, TM, Kada, S, Prasad, PV, Steele, M, Brooks, JT, et al.. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4:e2035057, https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.35057.","DOI":"10.1001\/jamanetworkopen.2020.35057"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_025","unstructured":"Hawlader, MDH, Rahman, ML, Nazir, A, Ara, T, Akiful Haque, MM, Saha, S, et al.. Belief, attitude, and intention to take COVID-19 vaccine among South asian population: a multi-country study. Int J Infect Dis. 2021 [Online];114: 1-10 . Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1201971221007591 [cited 2021 Oct 23]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_026","doi-asserted-by":"crossref","unstructured":"Berihun, G, Walle, Z, Berhanu, L, Teshome, D. Acceptance of COVID-19 vaccine and determinant factors among patients with chronic disease visiting dessie comprehensive specialized hospital, northeastern Ethiopia. Patient Prefer Adherence. 2021;15:1795\u2013805, https:\/\/doi.org\/10.2147\/ppa.s324564.","DOI":"10.2147\/PPA.S324564"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_027","unstructured":"Pagotto, V, Ferloni, A, Soriano, MM, D\u00edaz, M, Golde, MB, Gonz\u00e1lez, MI, et al.. Active surveillance of the Sputnik V vaccine in health workers. 2021. [Online]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2021.02.03.21251071v1 [cited 2021 Oct 23] p. 2021.02.03.21251071."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_028","doi-asserted-by":"crossref","unstructured":"Babamahmoodi, F, Saeedi, M, Alizadeh-Navaei, R, Hedayatizadeh-Omran, A, Mousavi, SA, Ovaise, G, et al.. Side effects and immunogenicity following administration of the Sputnik V COVID-19 vaccine among health care workers; an observational study in Iran. 2021. [Online]. Available from: https:\/\/www.researchsquare.com\/article\/rs-709499\/v1 [cited 2021 Oct 23].","DOI":"10.1038\/s41598-021-00963-7"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_029","unstructured":"Andrzej, J, Alexander, S, Miko\u0142aj, K, Vitaly, B. Mild adverse events of Sputnik V vaccine extracted from Russian language Telegram posts via BERT deep learning model | medRxiv. [Online]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2021.06.14.21258875v1 [cited 2021 Oct 26]."},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_030","doi-asserted-by":"crossref","unstructured":"Rela, M, Jothimani, D, Vij, M, Rajakumar, A, Rammohan, A. Auto-immune hepatitis following COVID vaccination. J Autoimmun. 2021;123:102688, https:\/\/doi.org\/10.1016\/j.jaut.2021.102688.","DOI":"10.1016\/j.jaut.2021.102688"},{"key":"2025121208563012537_j_JBCPP-2021-0345_ref_031","doi-asserted-by":"crossref","unstructured":"Remlabeevi, A, Mathew, T, Nair, GSH, Nair, GLR, Alex, MR. Adverse events and their association with comorbidities after first and second doses of Covishield vaccination among healthcare workers of Government owned medical colleges in Kerala. 2021. [Online]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2021.05.19.21257317v1 [cited 2021 Oct 25] p. 2021.05.19.21257317.","DOI":"10.1101\/2021.05.19.21257317"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0345\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:15:37Z","timestamp":1765538137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0345\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10,8]]},"published-print":{"date-parts":[[2023,7,26]]}},"alternative-id":["10.1515\/jbcpp-2021-0345"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2021-0345","relation":{},"ISSN":["2191-0286"],"issn-type":[{"type":"electronic","value":"2191-0286"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}